The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by establishing an Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC). The AD-SCCC will provide clinical study development, support domestic and international regulatory requirements, site monitoring, repository management, manuscript production, study archiving, and biostatistical support for ongoing and future clinical trials in the areas of autoimmune diseases, mucosal immunology, and primary immune deficiencies. Additional tasks include collaboration with the Division of Allergy, Immunology and Transplantation (DAIT) Clinical Data and Safety Management Center (CDSMC) and may include support on an emergent basis for other networks and clinical trials within the NIAID mission. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. 

Government

• County governments
• Special district governments
• State governments
• Federally recognized Native American tribal governments
• City or township governments
• Public and Indian housing authorities

Nonprofit

• Nonprofits non-higher education without 501(c)(3)
• Other Native American tribal organizations
• Nonprofits non-higher education with 501(c)(3)

Business

• Small businesses
• For-profit organizations other than small businesses

Miscellaneous

• Other

Education

• Public and state institutions of higher education
• Private institutions of higher education
• Independent school districts